rs3736228 LRP5
LRP5 A1330V homozygous. Reduced bone mineral density; increased fracture and osteoporosis risk.
What is rs3736228?
rs3736228 is a single-nucleotide polymorphism (SNP) in the LRP5 gene (LDL receptor-related protein 5). Each person carries two copies, one from each parent, so a result is reported as a pair of letters such as TT. The table below describes what studies associate with each genotype; the association is statistical, across populations, and is not a diagnosis.
What does each rs3736228 genotype mean?
| Genotype | Association | What the evidence says | Confidence |
|---|---|---|---|
| TT | elevated | LRP5 A1330V homozygous. Reduced bone mineral density; increased fracture and osteoporosis risk. | 82% |
| CT / TC | slightly elevated | LRP5 carrier. Moderately reduced bone density. | 78% |
| CC | typical / lower | Normal bone mineral density at LRP5 locus. | 82% |
How common is the T allele of rs3736228?
Minor-allele frequency by population (gnomAD / 1000 Genomes):
| European | 6.0% |
|---|---|
| East Asian | 16.0% |
| African | 1.0% |
| South Asian | 8.0% |
| Admixed American | 5.0% |
| Global | 7.0% |
Is rs3736228 on 23andMe and AncestryDNA chips?
Yes — it is genotyped directly on 23andMe V3, 23andMe V4, 23andMe V5, AncestryDNA V1, AncestryDNA V2. Orviva reads it from a raw-data export without imputation.
Sources
Upload your 23andMe, AncestryDNA or WeGene raw file → · Ask G2: “What is my genotype at rs3736228 and what does it mean for me?”
Genetic associations describe risk across populations, not a diagnosis for any one person. Most variants shift risk modestly and act alongside lifestyle, environment and other genes. Consumer DNA chips do not read every position and can be wrong at any single one. For general education only; talk to a clinician or genetic counsellor before acting on anything here, and never change a prescribed medicine without your prescriber.